Petra Pharma: Clinical Trials

1 trial sponsored by Petra Pharma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Unknown 1
Phase 21Unknown 1

Follow Petra Pharma: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors
Serabelisib, Canagliflozin 300mg - Breast Cancer, Endometrial Cancer
Phase 1 / Phase 2UnknownPetra Pharma602020-09-012020-05-21

Conditions studied

Breast Neoplasms (1)  ·  Colonic Neoplasms (1)  ·  Endometrial Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Lung Neoplasms (1)

Interventions

Canagliflozin (1)  ·  serabelisib (1)

Top investigators

Albert Yu, MD (1)